Back to Results

ODYSSEY: A randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in treating inflammatory lung injury and improving clinical outcomes associated with severe COVID-19 infection

Study category: Infectious Diseases

Is this Study for You?

Let's Get Started!

Description

The tradipitant therapy is being studied to explore if the administration prevents or treats the cytokine storm and acute respiratory distress syndrome leading to respiratory failure and high mortality in affected patients with COVID-19.

Details
Age

Adult

Eligibility

Adults aged 18-90 with confirmed laboratory COVID-19 infection and hospitalized for treatment.

Detailed Eligibility: Patients participating in other clinical trials are excluded

Phase

III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.

Type of Study

Treatment

Scope

National

Locations

Memorial Hospital Central
Memorial Hospital North

Principal Investigator
Ronald Rains

Ronald Rains

Study ID

Protocol Number: 20-6506

ClinicalTrials.gov: NCT04326426

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers